This week we finalised a complicated deal between our client who owns some valuable patents and trade secrets and a large US company.
It involved:
(a) the company subscribing for shares;
(b) the money being used to repay debt;
(c) the company agreeing to fund further development of some new technology;
(d) a licensing deal with a related company to commercialise the products;
(e) the company getting five separate options to purchase more share after commercialisation of the products, for a percentage of the gross income from the sale the products in the previous year;
(f) various other minor documents; and
(g) Two executives and a lawyer flying out from the United States, arriving on Tuesday to finalise the document and sign them all before flying back again Thursday morning at 2.00am.